TRU Independence Asset Management 2 LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 340 shares of the company’s stock, valued at approximately $29,000.
A number of other large investors also recently added to or reduced their stakes in CL. Wolff Wiese Magana LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $25,000. Advisory Alpha LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth about $28,000. Grant Street Asset Management Inc. bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $28,000. Encompass Wealth Advisors LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $29,000. Finally, Accel Wealth Management bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $33,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Shares of CL stock opened at $79.62 on Thursday. The firm has a market capitalization of $67.48 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 3.83 and a beta of 0.59. The company has a debt-to-equity ratio of 6.50, a current ratio of 0.97 and a quick ratio of 0.62. The business has a fifty day moving average of $76.89 and a 200 day moving average of $80.38. Colgate-Palmolive has a 1 year low of $65.54 and a 1 year high of $86.41.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Thursday, January 28th. The company reported $0.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.01. The business had revenue of $4.32 billion during the quarter, compared to analyst estimates of $4.15 billion. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. The company’s revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the business posted $0.73 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.05 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 14th. Shareholders of record on Wednesday, April 21st will be paid a dividend of $0.45 per share. The ex-dividend date is Tuesday, April 20th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.26%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.44. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.
In related news, insider Jennifer Daniels sold 20,692 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 4th. The stock was sold at an average price of $78.65, for a total value of $1,627,425.80. Following the completion of the transaction, the insider now owns 55,585 shares in the company, valued at approximately $4,371,760.25. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Philip G. Shotts sold 346 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total value of $26,697.36. Following the completion of the transaction, the vice president now owns 41,128 shares of the company’s stock, valued at approximately $3,173,436.48. The disclosure for this sale can be found here. Insiders have sold a total of 30,810 shares of company stock valued at $2,418,650 in the last quarter. Company insiders own 0.78% of the company’s stock.
A number of equities analysts have recently weighed in on CL shares. Credit Suisse Group raised Colgate-Palmolive from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $70.00 to $80.00 in a research note on Monday, February 1st. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price target for the company. in a research note on Thursday, January 28th. Royal Bank of Canada downgraded Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price objective on the stock. in a research report on Monday, January 4th. Berenberg Bank upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 price objective on the stock in a research report on Tuesday, January 26th. Finally, Sanford C. Bernstein began coverage on Colgate-Palmolive in a research report on Tuesday, January 19th. They set an “underperform” rating and a $77.00 price objective on the stock. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $81.91.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
See Also: What is net income?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.